Press-release for stocks

| 2.06% | O: 1.03% H: 2.65% C: 1.02%
active test cancer for study

MustGrow Biologics to Present at the Planet MicroCap Showcase
Published: 2024-04-17 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M

| 2.8% | O: -0.04% H: 0.28% C: -0.16%
microcap

Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
Published: 2024-04-16 (Crawled : 17:00) - biospace.com/
IINN | $1.88 -1.05% -1.06% 48K

Professional, Scientific, and T...

| -1.55% | O: 0.0% H: 1.55% C: 0.0%
art100 device for

Sunshine Biopharma Announces Reverse Stock Split
Published: 2024-04-12 (Crawled : 17:00) - biospace.com/
SBFM | $1.235 -14.24% -22.03% 5.9M

| 1553.27% | O: -2.41% H: 0.0% C: -5.76%
biopharma

Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
Published: 2024-04-11 (Crawled : 17:00) - biospace.com/
KPRX | $0.601 23.92% 19.3% 1.2M

| -19.3% | O: 3.23% H: 0.16% C: -1.79%
granted approval pharmaceuticals research for grant trial foundation study

Biopharma Layoff Tracker 2024: Sanofi, Novartis, Boehringer and More Cut Staff
Published: 2024-04-10 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
RLYB | News | $1.84 3.96% 3.8% 240K

| 7.27% | O: -3.03% H: 4.38% C: 1.87%
JNJ | News | $149.56 0.3% 0.0% 9.1M

| -1.47% | O: 0.21% H: 0.0% C: 0.0%
VXRT | News | $0.7422 -2.66% -2.74% 1.5M

| -26.92% | O: 0.0% H: 0.0% C: -2.88%
TXMD | News | $1.875 -0.27% -0.27% 21K

| -12.56% | O: 0.47% H: 3.7% C: -2.31%
SNY | News | $47.69 1.15% 1.13% 1.7M

| -2.64% | O: -0.32% H: 0.0% C: 0.0%
PTCT | News S | $25.38 -2.27% -2.32% 750K

| -5.91% | O: -3.73% H: 2.9% C: 1.28%
NKTR | News | $1.415 4.04% 3.89% 1.1M

| 8.8% | O: -3.2% H: 14.88% C: 6.61%
MOR | News | $18.04 0.45% 0.44% 180K

| -1.05% | O: -0.91% H: 0.0% C: 0.0%
GLPG | News | $29.47 1.38% 1.36% 120K

| -8.15% | O: -0.19% H: 0.0% C: -1.49%
AMRN | News | $0.8827 1.96% 1.93% 760K

| -17.92% | O: -0.94% H: 0.0% C: -0.95%
GOOGL | News S | $158.17 1.21% 1.19% 21M

| -0.2% | O: -0.25% H: 0.26% C: -0.04%
GOOG | News 4 | $159.82 1.18% 1.17% 16M

| -0.12% | O: -0.16% H: 0.18% C: -0.14%
OCX | News | $2.5 -0.4% -0.4% 23K

| -13.75% | O: -0.1% H: 0.0% C: 0.0%
biopharma

Biopharma Layoff Tracker 2024: Novartis, Sanofi, Boehringer and More Cut Staff
Published: 2024-04-09 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

| -1.38% | O: 0.28% H: 0.0% C: 0.0%
RLYB | News | $1.84 3.96% 3.8% 240K

| 5.99% | O: 0.0% H: 0.0% C: -1.2%
JNJ | News | $149.56 0.3% 0.0% 9.1M

| -1.77% | O: -0.3% H: 0.0% C: 0.0%
VXRT | News | $0.7422 -2.66% -2.74% 1.5M

| -29.63% | O: 1.85% H: 0.0% C: -5.45%
TXMD | News | $1.875 -0.27% -0.27% 21K

| -12.96% | O: 0.0% H: 8.33% C: -0.46%
SNY | News | $47.69 1.15% 1.13% 1.7M

| -2.21% | O: -0.38% H: 0.95% C: 0.83%
PTCT | News S | $25.38 -2.27% -2.32% 750K

| -3.39% | O: 0.26% H: 2.86% C: 2.41%
NKTR | News | $1.415 4.04% 3.89% 1.1M

| 3.82% | O: -0.76% H: 3.08% C: -3.85%
MOR | News | $18.04 0.45% 0.44% 180K

| -0.99% | O: 0.06% H: 0.22% C: 0.0%
GLPG | News | $29.47 1.38% 1.36% 120K

| -8.76% | O: 0.0% H: 0.39% C: -0.66%
AMRN | News | $0.8827 1.96% 1.93% 760K

| -18.69% | O: -0.93% H: 4.25% C: 0.0%
GOOGL | News S | $158.17 1.21% 1.19% 21M

| 2.27% | O: 2.14% H: 1.59% C: 0.33%
GOOG | News 4 | $159.82 1.18% 1.17% 16M

| 2.41% | O: 2.02% H: 1.61% C: 0.5%
OCX | News | $2.5 -0.4% -0.4% 23K

| -12.24% | O: 1.75% H: 0.0% C: 0.0%
biopharma

Merck, Genmab, Kintara and More Continue 2024 M&A Upswing
Published: 2024-04-08 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M

| -2.24% | O: -0.48% H: 0.0% C: 0.0%

Biopharma Layoff Tracker 2024: Carisma, Omega, Xilio and More Cut Staff
Published: 2024-04-04 (Crawled : 17:00) - biospace.com/
RLYB | News | $1.84 3.96% 3.8% 240K

| 5.99% | O: 1.2% H: 0.0% C: -6.51%
JNJ | News | $149.56 0.3% 0.0% 9.1M

| -5.48% | O: -1.51% H: 0.0% C: 0.0%
VXRT | News | $0.7422 -2.66% -2.74% 1.5M

| -38.21% | O: -0.81% H: 6.56% C: -7.38%
TXMD | News | $1.875 -0.27% -0.27% 21K

| -15.51% | O: 1.12% H: 0.0% C: -0.44%
SNY | News | $47.69 1.15% 1.13% 1.7M

| -3.65% | O: 1.18% H: 0.0% C: 0.0%
PTCT | News S | $25.38 -2.27% -2.32% 750K

| -10.45% | O: 0.45% H: 1.0% C: -4.5%
NKTR | News | $1.415 4.04% 3.89% 1.1M

| 30.77% | O: 3.85% H: 28.7% C: 22.22%
MOR | News | $18.04 0.45% 0.44% 180K

| -0.72% | O: 0.55% H: 0.0% C: -0.66%
GLPG | News | $29.47 1.38% 1.36% 120K

| -8.56% | O: 0.44% H: 0.69% C: -0.38%
AMRN | News | $0.8827 1.96% 1.93% 760K

| -17.92% | O: 0.94% H: 0.0% C: -0.93%
GOOGL | News S | $158.17 1.21% 1.19% 21M

| 0.88% | O: -0.76% H: 0.0% C: 0.0%
GOOG | News 4 | $159.82 1.18% 1.17% 16M

| 1.01% | O: -0.84% H: 0.0% C: 0.0%
OCX | News | $2.5 -0.4% -0.4% 23K

| -14.63% | O: -3.4% H: 3.52% C: 3.52%
biopharma

IceCure Submits FDA Regulatory Filing for New XSense™ Cryoablation System with Cryoprobes
Published: 2024-04-02 (Crawled : 17:00) - biospace.com/
ICCM | $1.22 0.82% 66K

| -5.43% | O: 4.65% H: 0.0% C: -0.74%
fda system

Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
INCY | $51.62 -0.58% -0.58% 2.5M

| -9.41% | O: -0.6% H: 0.0% C: -0.58%
license collaboration asia agreement

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NRXP | $3.1 3.33% 3.23% 110K

Professional, Scientific, and T...

| 535.73% | O: 895.97% H: 14.34% C: 11.7%
business year update pharmaceuticals financial results

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
SBFM | $1.235 -14.24% -22.03% 5.9M

| 2280.17% | O: 83.97% H: 18.6% C: -4.31%
year biopharma results

Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
CRL | News | $240.13 3.26% 0.0% 610K

Commercial Services

| -14.17% | O: 0.06% H: 0.81% C: -0.88%

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 1, 2024
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
ABEO | News | $3.395 -53.87% -116.79% 5.5M

| 0.75% | O: -1.16% H: 7.48% C: 6.93%
nasdaq grants therapeutics employee

Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
VTGN | $4.83 1.05% 1.04% 190K

| -9.47% | O: -2.27% H: 0.0% C: 0.0%
positive treatment results study

Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
ABT | News | $107.59 0.49% -0.09% 3.8M

| -5.44% | O: 0.38% H: 0.0% C: -1.38%
fda test rapid blood clearance

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
BIAF | $2.56 -14.67% -17.19% 400K

| 48.51% | O: 2.97% H: 1.92% C: 0.48%
year financial results

Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
VRTX | $404.93 1.25% 1.43% 1.1M